new injectable biologic for moderate to severe plaque psoriasis called Stelara (stel-AR-a)
November 2009
You'll soon hear about a new injectable biologic for moderate to severe plaque psoriasis called Stelara (stel-AR-a).
It's the first of a new class. It inhibits the inflammatory proteins interleukin-12 and -23...instead of tumor necrosis factor.
Some evidence suggests that Stelara might be more effective than Enbrel for psoriasis. But this isn't proven yet...and there are concerns about long-term safety.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote